These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7292446)

  • 21. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.
    De Marco L; Shapiro SS
    J Clin Invest; 1981 Aug; 68(2):321-8. PubMed ID: 6790574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of colloidal gold granules, coated with bovine factor VIII, to human platelet membranes.
    Furlan M; Horisberger M; Perret BA; Beck EA
    Br J Haematol; 1981 Jun; 48(2):319-24. PubMed ID: 6786321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human platelet aggregation by PAF and thromboxane production.
    Violi F; Praticò D; Ghiselli A; Alessandri C; Cordova C
    Thromb Res; 1987 Oct; 48(2):265-6. PubMed ID: 3424290
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
    J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of extracellular proteases from gran-negative bacteria on the interaction of von Willebrand factor with human platelets.
    Cooper HA; Bennett WP; Kreger A; Lyerly D; Wagner RH
    J Lab Clin Med; 1981 Mar; 97(3):379-89. PubMed ID: 6780641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybridoma antibodies to human von Willebrand factor. II. Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium.
    Meyer D; Baumgartner HR; Edginton TS
    Br J Haematol; 1984 Aug; 57(4):609-20. PubMed ID: 6204681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
    Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 35. Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats.
    de Gaetano G; Donati MB; Reyers-Degli Innocenti I; Roncaglioni MC
    Experientia; 1975 Apr; 31(4):500-2. PubMed ID: 1120536
    [No Abstract]   [Full Text] [Related]  

  • 36. [Binding of factor VIII/Willebrand to Bernard-Soulier and thrombasthenic platelets (author's transl)].
    Ruan C; Tobelem G; Caen JP
    Nouv Rev Fr Hematol (1978); 1981; 23(2):89-93. PubMed ID: 6794004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets.
    Jenkins CS; Clemetson KJ; Lüscher EF
    J Lab Clin Med; 1979 Feb; 93(2):220-31. PubMed ID: 311800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.